Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers

Maşallah ERMAYA, (Van Bölge Eğitim ve Araştırma Hastanesi, Van, Türkiye)
Halit Demir, (Van Yüzüncü Yıl Üniversitesi, Fen Fakültesi, Biyokimya Bölümü, Van,Türkiye)
Canan Demir, (Van Yüzüncü Yıl Üniversitesi, Sağlık Meslek Yüksek Okulu, Van, Türkiye.)
Huseyin Kanmaz (Van Bölge Eğitim ve Araştırma Hastanesi, Onkoloji Kliniği, Van, Türkiye)
Clinical and Experimental Health Sciences
2 0
Yıl: 2021 Cilt: 11 Sayı: 3 Sayfa Aralığı: 542 - 546 Metin Dili: İngilizce DOI: 10.33808/clinexphealthsci.861254 İndeks Tarihi: 17-01-2022

Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers

Öz:
Objective: The purpose of this study is to determine the relationship between enzymatic antioxidants such as glutathione reductase and glutathione s-transferase and prolidase and adenosine deaminase in patients diagnosed with pancreatic cancer. Methods: Prolidase, adenosine deaminase, glutathione s-transferase and glutathione reductase activities were determined spectrophotometrically in blood sera collected from patients and healthy control subjects included in the study. Results: In patients with pancreatic cancer, the mean value of glutathione reductase and glutathione s-transferase enzymes decreased, while the mean value of prolidase, and adenosine deaminase, enzyme activities increased (p <0.05). Conclusion: In this study, in which prolidase, enzyme activity was first measured in pancreatic cancer, high prolidase, activity can be evaluated as a factor that increases the risk of cancer. Prolidase, adenosine deaminase, glutathione reductase and glutathione s-transferase enzyme activities may play an important role in the etiopathogenesis of pancreatic cancer.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Mills SE. Sternberg’s Diagnostic surgical pathology. Lippincott Williams & Wilkins. 2010; 2: 1442-1443.
  • [2] Abeloff MD, Armitage JO, Niederhuber JE. Carcinoma of the Pancreas. Clin Oncol. 2008;4 thed. Philadelphia p. 1596.
  • [3] Wilkowski R, Boeck S, Ostermaier S. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine – cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study. Br J Cancer 2009;101: 1853-59.
  • [4] Jemal A, Siegel R, Ward E. Cancer statistics. CA Cancer J Clin. 2008;58 (2): 71 – 96.
  • [5] Bell ET. Carcinoma of the pancreas, 1.A clinical and pathologic study of 609 necropsied cases, 11. The relation of carcinoma of the pancreas to diabetes mellitus.1957; Am J Pathol 33 – 499.
  • [6] Nakase A, Watsumoto Y, Uchida K.Surgical treatment of cancer of the pancreas and the periampullary region; cumulative results in 5 7 institutions in Japan. Ann Surg 1977;185: 52.
  • [7] Cubilla A.X , Fitzgeral P.J. Duct cell adenocarcinoma.In Sommers S.C., Rosen PJP. (eds.): Pankreas Cancer: Pathology Annual. 1978; Part 1, P. 241. New York, Appelton – CenturyCrofts.
  • [8] Greer JB, Yazer M, Raval J. Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol 2010;16[44]: 5588-5591.
  • [9] Hart AR. Pancreatic cancer: any prospects for prevention? Postgraduate Medical Journal. 1999;75[887]:521-526.
  • [10] Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. Haematologica 1994;79:13-18.
  • [11] Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors, J Cell Biochem.1997;67: 166-175.
  • [12] McRae PA, Porter BE. The perineuronal net component of the extracellular matrix in plasticity and epilepsy. Neurochem Int 2012;61: 963-972.
  • [13] Lizuka H, Kouzumi H, Kamigaki K, Aoyagi T, Miura Y. Two forms of adenosine deaminase in pig epidermis. J.Dermatol 1981;8: 91-95.
  • [14] Oosthizen HM, Ungerer J.P, Bissbort S.H. Kinetic determination of serum adenosine deaminase. Clinical Chemistry.1993; 39 (10): 2182-2185.
  • [15] Dissing J, Kaudsen B.Adenosine deaminase deficiency and combined immunodeficiency syndrome. Lancet 1972;2: 1316.
  • [16] Baganha MF, Pego A, Lima M.A, Gaspar E.U, Pharma B. Serum anf plevral edenosine deaminase correlation with lymphocytic populations. Chest, 1990;97: 605-610.
  • [17] Chotfıner EG, Cloft HJ, Tartaglia AP, Mitchell S.B. Elevated adenosine deaminase activity and hereditary hemolytic anemia J Clin Invest 1987;79:1001-1005.
  • [18] Meister A. The Glutathione-Ascorbic Acid Antioxidant Systems in An J Biol Chem 1994; 269: 9397-9400.
  • [19] Şenturk M, Talaz O, Cavdar H, Ekinci D, Kufrevioglu OI. Yeni sentezlenen bazı organik nitratların glutatyon redüktaz enzim kinetiği üzerine etkilerinin incelenmesi. Bioorganic & Medicinal Chemistry Letters.2009;19: 3661-3663.
  • [20] Arıas I.M, Jacoby W.B. Glutathione: Metabolism and Function. Kroc. Found. Series.1976;6,335.
  • [21] Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin. Chim. Acta.1982; 125: 193– 205.
  • [22] Giustı G. Adenosinedeaminase. İn: HV BergmeyerandWeinheim [eds]. Methods of Enzymatic Analysis. Deerfield Beach, Fl: VerlagChemmie.1974;1092 – 99.
  • [23] Goldberg DM, Spooner R.J. Methods of enzymatic analysis. Bergmeyer HV.1983; 3: 258-265.
  • [24] Mannervik B, Guthenberg C. Glutathionetransferase (human plasenta). Meth.Enzymol 1981; 77: 231-235.
  • [25] Abeloff MD, Armitage JO, Niederhuber JE. Carcinoma of the Pancreas. Clinical Oncology.2 008;4 thed. Philadelphia p. 1596.
  • [26] Wilson DK, Rudolph FB, Quiocho FA. Atomic Structure of Adenosine Deaminase Complexed with TransitionState Analge: Understanding Catalysis and Imunodefiency Mutations. Science 1991; 252: 1278-1284.
  • [27] Durak İ, Işık ACÜ, Canbolat O, Akyol Ö, Kavutçu M. Durak I, Işik AC, Canbolat O, Akyol O, Kavutçu M. Adenosine deaminase, 5’ nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues. Free Radic Biol Med 1993, 15;681-684.
  • [28] Durak İ, Çetin R, Canbolat O, Çetin D, Yurtaslanı Z, Ünal A. Adenosine deaminase, 5’nucleotidase guanase and cytidine deaminase in gastric tissues from patients with gastric cancer. Cancer Lett.1994;15;84(2):199-202.
  • [29] Akyol Ö, Arslanoğlu R, Durak İ. Avtivities of free radical and DNA turn-over enzymes in cancerous and non-cancerous brain tissues. Redox Report.1995;1,255-259.
  • [30] Canbolat O, Durak İ, Çetin R, Kavutçu M, Demirci S, Öztürk S. Activities of adenosine deaminase, 5’nucleotidase,guanase and cytidine deaminase enzymes in cancerous and non,cancerous human breast tissues. Breast Cancer Research and Treatment.1996; 37: 189-193.
  • [31] Segura RM, Pascual C, Ocana I. Adenosine deaminase in body fluid: A useful diagnostic tool in tuberculosis. Clin Biochem 1989; 22: 141-148.
  • [32] Light R.W. Clinical manifestations and useful tests. In: Light RW [ed]. Pleural Diseases. Baltimore: Williams &Wilkins.1995;95[8]: 36-74.
  • [33] Koehler LH, Benz E.J. Serum adenosine deaminase methodology and clinical applications. Clin Chem 1962;8: 133-40.
  • [34] Nishikawa H, Suga M, Ando M. Serum adenosine deaminase activity with Mycoplasma pneumoniae. Chest. 1988; 94: 1315.
  • [35] Aghaei M, Karami F, Salami S, Atri M. Diagnostic Value of Adenosine Deaminase Activity in Benign and Malignant Breast Tumors. Clin Bichem 2005;38(10):887-891.
  • [36] Memişoğulları R. Diyabette Serbest Radikallerin Rolü ve Antioksidanların Etkisi. Düzce Tıp Fakültesi Dergisi.2005; 3: 30–39.
  • [37] Björkhem-Bergman L, Jönsson K, Eriksson LC, Olsson J.M, Lehmann S, Paul C, Björnstedt M. Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity :Effects on thioredoxin reductase and glutathione reductase. Biochem Pharmacol. 2002;63[10]:1875-84.
  • [38] Navarro J, Obrador E, Carretero J, Petschen I, Aviñó J, Perez P, Estrela JM. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med. 1999;26(3-4):410-8.
  • [39] Tisdale MJ, Mahmoud M.B. Activities of free radical metabolizing enzymes in tumours. Br J Cancer. 1983;Jun;47[6]:809-12.
  • [40] Yavuz İ.H, Özaydin Yavuz G, Güneş Bilgili S, Demir H, Demir C. Deri kanseri hastalarının serum oksidatif stres parametrelerinin değerlendirilmesi. Bozok Tıp Dergisi.2018; 8(3): 127-133. (Turkish)
  • [41] Memişoğulları R. Diyabette Serbest Radikallerin Rolü ve Antioksidanların Etkisi. Düzce Tıp Fakültesi Dergisi.2005; 3: 30– 39. (Turkish)
  • [42] Hayes J.D, Flanagan J.U, Jowsey I.R. Glutathione transferases. Annual Review of Pharmacology and Toxicology.2005; 45: 51-88.
  • [43] Knapena MF, Zusterzeel PL, Peters W.H, Steegers E.A. Glutathione and glutathi-one-related enzymes in reproduction. A review. Eur J Obstet Gynecol Reprod Biol. 1999;82: 171-84.
  • [44] Lin CC, Yin MC. B Vitamins Deficiency and Decreased AntiOxidative State in Patients with Liver Cancer. Eur J Nutr, 2007; 46(5): 293-9.
  • [45] Gonzales R,Auclair C, Voisin E, Gautero H, Dhermy D, Boivin P. Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant diseases. Cancer Res. 1984; 44(9): 4137 – 9.
  • [46] Turan K, Uçkan K, Sarıkaya E, Demir H, Demir C. Investigation of prolidase, adenosine deaminase, glutatatione s-transferase and glutatione reductase activites in patients with abortus ımminens. J Clin Anal Med. 2017; 8(10): 519-522.
  • [47] Öner İ.Y, Gürdöl F, Öner P. Serup prolidaz I aktivitesinin kemik yapım – yıkım indeksi olarak değerlendirilmesi. İst Tıp Fak Mecmuası.1999; 62: 301-306. (Turkish)
  • [48] Hauptmann, M, Wilson D.F, Erecinska M. High affinity proline uptake in rat brain synaptosomes. FEBS Lett. 1983;161: 301- 305.
APA ermaya m, DEMIR H, DEMİR C, Kanmaz H (2021). Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. , 542 - 546. 10.33808/clinexphealthsci.861254
Chicago ermaya masallah,DEMIR HALIT,DEMİR Canan,Kanmaz Huseyin Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. (2021): 542 - 546. 10.33808/clinexphealthsci.861254
MLA ermaya masallah,DEMIR HALIT,DEMİR Canan,Kanmaz Huseyin Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. , 2021, ss.542 - 546. 10.33808/clinexphealthsci.861254
AMA ermaya m,DEMIR H,DEMİR C,Kanmaz H Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. . 2021; 542 - 546. 10.33808/clinexphealthsci.861254
Vancouver ermaya m,DEMIR H,DEMİR C,Kanmaz H Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. . 2021; 542 - 546. 10.33808/clinexphealthsci.861254
IEEE ermaya m,DEMIR H,DEMİR C,Kanmaz H "Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers." , ss.542 - 546, 2021. 10.33808/clinexphealthsci.861254
ISNAD ermaya, masallah vd. "Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers". (2021), 542-546. https://doi.org/10.33808/clinexphealthsci.861254
APA ermaya m, DEMIR H, DEMİR C, Kanmaz H (2021). Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. Clinical and Experimental Health Sciences, 11(3), 542 - 546. 10.33808/clinexphealthsci.861254
Chicago ermaya masallah,DEMIR HALIT,DEMİR Canan,Kanmaz Huseyin Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. Clinical and Experimental Health Sciences 11, no.3 (2021): 542 - 546. 10.33808/clinexphealthsci.861254
MLA ermaya masallah,DEMIR HALIT,DEMİR Canan,Kanmaz Huseyin Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. Clinical and Experimental Health Sciences, vol.11, no.3, 2021, ss.542 - 546. 10.33808/clinexphealthsci.861254
AMA ermaya m,DEMIR H,DEMİR C,Kanmaz H Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. Clinical and Experimental Health Sciences. 2021; 11(3): 542 - 546. 10.33808/clinexphealthsci.861254
Vancouver ermaya m,DEMIR H,DEMİR C,Kanmaz H Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers. Clinical and Experimental Health Sciences. 2021; 11(3): 542 - 546. 10.33808/clinexphealthsci.861254
IEEE ermaya m,DEMIR H,DEMİR C,Kanmaz H "Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers." Clinical and Experimental Health Sciences, 11, ss.542 - 546, 2021. 10.33808/clinexphealthsci.861254
ISNAD ermaya, masallah vd. "Investigation of Average Values of Prolidase, Adenozin Deaminase, Glutathione S-Transferase and Glutathione Reductase Enzymes in Pancreas Cancers". Clinical and Experimental Health Sciences 11/3 (2021), 542-546. https://doi.org/10.33808/clinexphealthsci.861254
Sayfa Oluşturulma Tarihi
24-04-2024 14:32

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları